Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: Long-lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine.
Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: Long-lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine.
复制标题
DOI:
10.1016/j.neuropharm.2020.108251
复制
发表时间:
2020-10-01
影响因子:
4.7
通讯作者:
Zhan CG
中科院分区:
文献类型:
--
作者:
Zhang T;Wei H;Deng J;Zheng F;Zhan CG
It is a grand challenge to develop a truly effective treatment of substance use disorder (SUD), particularly for cocaine and other drugs without an FDA-approved treatment available, because a truly effective therapy must effectively block the drug’s physiological and reinforcing effects during the entire period of treatment in order to achieve the long-time abstinence required by the FDA. Whether a biologic, such as monoclonal antibody, vaccine, or therapeutic enzyme, can be truly effective for SUD treatment or not has been the subject of extensive debate. The main debate question is whether a biologic, particularly an exogenous enzyme, can effectively block the drug’s reinforcing effect. In this report, we demonstrate that a modest dose of a recently redesigned long-acting cocaine hydrolase, CocH3-Fc(M6), can be used to effectively block the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine for a sufficiently long period of time. For example, a dose of 3 mg/kg CocH3-Fc(M6) completely blocked the discriminative stimulus and reinforcing effects for 24/25 days and continued to significantly attenuate/decrease the cocaine effects for at least 29 days in rats. All the animal data consistently suggest that the long-acting cocaine hydrolase is a truly promising candidate of enzyme therapy for treatment of cocaine use disorder.
登录
查看更多内容
影响因子:
14.8
作者:
Solinas, Marcello;Panlilio, Leigh V.;Goldberg, Steven R.
通讯作者:
Goldberg, Steven R.
影响因子:
5.1
作者:
Chen, Xiabin;Deng, Jing;Zheng, Fang
通讯作者:
Zheng, Fang
DOI:
10.1073/pnas.0507332102
发表时间:
2005-11-15
影响因子:
11.1
作者:
Pan, YM;Gao, DQ;Zhan, CG
通讯作者:
Zhan, CG
DOI:
10.1038/npp.2008.135
发表时间:
2009-04
期刊:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
影响因子:
--
作者:
通讯作者:
--
影响因子:
3.4
作者:
Schindler CW;Justinova Z;Lafleur D;Woods D;Roschke V;Hallak H;Sklair-Tavron L;Redhi GH;Yasar S;Bergman J;Goldberg SR
通讯作者:
Goldberg SR